Gene · 4017
Papers2,536
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,536
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differentiating gastrointestinal tuberculosis and Crohn's disease- a comprehensive review. | BMC Gastroenterol | 2023 | 37468869 | PubTator, text mining | PubMed |
| Identification of key DNA methylation changes on fasting plasma glucose: a genome-wide DNA methylation analysis in Chinese monozygotic twins. | Diabetol Metab Syndr | 2023 | 37461060 | PubTator, text mining | PubMed |
| Lysyl oxidase like-2 in fibrosis and cardiovascular disease. | Am J Physiol Cell Physiol | 2023 | 37458436 | PubTator, text mining | PubMed |
| Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer's disease. | Cereb Circ Cogn Behav | 2023 | 37457664 | PubTator, text mining | PubMed |
| Exploring the Interplay between Polyphenols and Lysyl Oxidase Enzymes for Maintaining Extracellular Matrix Homeostasis. | Int J Mol Sci | 2023 | 37446164 | PubTator, text mining | PubMed |
| Comparative Analysis of Water Extracts from Roselle (Hibiscus sabdariffa L.) Plants and Callus Cells: Constituents, Effects on Human Skin Cells, and Transcriptome Profiles. | Int J Mol Sci | 2023 | 37446030 | PubTator, text mining | PubMed |
| Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma. | Cancers (Basel) | 2023 | 37444617 | PubTator, text mining | PubMed |
| Biomarker Discovery in Rare Malignancies: Development of a miRNA Signature for RDEB-cSCC. | Cancers (Basel) | 2023 | 37444397 | PubTator, text mining | PubMed |
| How circulating tumor cluster biology contributes to the metastatic cascade: from invasion to dissemination and dormancy. | Cancer Metastasis Rev | 2023 | 37442876 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review. | Front Oncol | 2023 | 37441422 | PubTator, text mining | PubMed |
| Copper in cancer: from limiting nutrient to therapeutic target. | Front Oncol | 2023 | 37427098 | PubTator, text mining | PubMed |
| Embedded Bioprinting of Breast Tumor Cells and Organoids Using Low-Concentration Collagen-Based Bioinks. | Adv Healthc Mater | 2023 | 37422447 | PubTator, text mining | PubMed |
| Identification of hub genes and microRNAs with prognostic values in esophageal cancer by integrated analysis. | Noncoding RNA Res | 2023 | 37416747 | PubTator, text mining | PubMed |
| Deciphering the contributions of cuproptosis in the development of hypertrophic scar using single-cell analysis and machine learning techniques. | Front Immunol | 2023 | 37409114 | PubTator, text mining | PubMed |
| Expression of circular RNAs in myelodysplastic neoplasms and their association with mutations in the splicing factor gene SF3B1. | Mol Oncol | 2023 | 37408496 | PubTator, text mining | PubMed |
| Potential pathological and molecular mechanisms of temporomandibular joint osteoarthritis. | J Dent Sci | 2023 | 37404608 | PubTator, text mining | PubMed |
| Denatured collagen inhibits neuroblastoma tumor-sphere migration and growth via the LOX/LOXL2 - FAK signaling pathway. | J Therm Biol | 2023 | 37399743 | PubTator, text mining | PubMed |
| Treatment of liver fibrosis: Past, current, and future. | World J Hepatol | 2023 | 37397931 | PubTator, text mining | PubMed |
| Mechanistic insight into lysyl oxidase in vascular remodeling and angiogenesis. | Genes Dis | 2023 | 37396555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4017/papers?page=18